DaVita
DVA
A$222.72
Share price
0.10%
Change (1 day)
4.85%
Change (1 year)
Categories
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.
Revenue for DaVita (DVA)
Revenue in 2025 (TTM): A$19.95 Billion
According to DaVita's latest financial reports the company's current revenue (TTM 
) is A$19.87 Billion. In 2024 the company made a revenue of A$20.60 Billion an increase over the revenue in the year 2023 that were of A$17.81 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for DaVita from 1996 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | A$19.95 B | -3.15% |
| 2024 | A$20.60 B | 15.63% |
| 2023 | A$17.81 B | 4.45% |
| 2022 | A$17.06 B | 6.45% |
| 2021 | A$16.02 B | 6.69% |
| 2020 | A$15.02 B | -7.65% |
| 2019 | A$16.26 B | 0.47% |
| 2018 | A$16.18 B | 16.2% |
| 2017 | A$13.93 B | -26.85% |
| 2016 | A$19.04 B | 0.67% |
| 2015 | A$18.91 B | 21% |
| 2014 | A$15.63 B | 18.54% |
| 2013 | A$13.18 B | 68.47% |
| 2012 | A$7.82 B | 17.29% |
| 2011 | A$6.67 B | 5.19% |
| 2010 | A$6.34 B | -6.69% |
| 2009 | A$6.80 B | -15.24% |
| 2008 | A$8.02 B | 33.24% |
| 2007 | A$6.02 B | -2.75% |
| 2006 | A$6.19 B | 57.37% |
| 2005 | A$3.93 B | 32.45% |
| 2004 | A$2.97 B | 7.89% |
| 2003 | A$2.75 B | -16.36% |
| 2002 | A$3.29 B | 1.77% |
| 2001 | A$3.23 B | 21.68% |
| 2000 | A$2.65 B | 20.88% |
| 1999 | A$2.19 B | 11.76% |
| 1998 | A$1.96 B | 145.51% |
| 1997 | A$0.80 B | 133.41% |
| 1996 | A$0.34 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Tenet Healthcare THC | A$31.45 B | 58.23% | 🇺🇸 USA |
 Pediatrix Medical Group MD | A$3.02 B | -84.76% | 🇺🇸 USA |
 Universal Health Services
UHS | A$24.65 B | 24.02% | 🇺🇸 USA |
 LabCorp LH | A$20.19 B | 1.61% | 🇺🇸 USA |